[
  {
    "ts": null,
    "headline": "Did Xevo CDMS Launch Just Shift Waters' (WAT) Investment Narrative in Next-Gen Therapeutics?",
    "summary": "Earlier this month, Waters Corporation launched the Xevo Charge Detection Mass Spectrometer (CDMS), offering direct, individual-particle mass measurement of mega-mass biomolecules critical to next-generation therapeutics and structural biology. This innovation enables scientists to analyze complex biomolecules, such as viral vectors and mRNA therapeutics, using up to 100-fold less sample volume and delivering results in under ten minutes, addressing major industry challenges in advanced...",
    "url": "https://finnhub.io/api/news?id=d5c3f86576827cdd064849540a933546ccdcda896743450e794cddaabd994184",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760955133,
      "headline": "Did Xevo CDMS Launch Just Shift Waters' (WAT) Investment Narrative in Next-Gen Therapeutics?",
      "id": 137168917,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Earlier this month, Waters Corporation launched the Xevo Charge Detection Mass Spectrometer (CDMS), offering direct, individual-particle mass measurement of mega-mass biomolecules critical to next-generation therapeutics and structural biology. This innovation enables scientists to analyze complex biomolecules, such as viral vectors and mRNA therapeutics, using up to 100-fold less sample volume and delivering results in under ten minutes, addressing major industry challenges in advanced...",
      "url": "https://finnhub.io/api/news?id=d5c3f86576827cdd064849540a933546ccdcda896743450e794cddaabd994184"
    }
  }
]